Candela Laser gains additional approval in Japan:
This article was originally published in Clinica
Executive Summary
Candela (US) has been granted Japanese approval to market the LaserTripter MDL-3000 for the urology market. The company already has six products approved by the Japanese Ministry of Health & Welfare which generated revenues of $7.59 million in fiscal 1994 (ended July 2nd). Japan, where Candela is leader in the urology market, is the company's largest market outside the US, says president and CEO Gerard Puorro. Corporate revenues were $29.61 million in 1994.